Does an individual estimation of halflife improve the results of radioiodine therapy of Graves' disease?
Walter, M.A.; Müller, B.; Müller-Brand, J.
NUKLEARMEDIZIN. Nuclear Medicine 42(3): N29; Author Reply N29
2003
ISSN/ISBN: 0029-5566 PMID: 12848158 Document Number: 559091
Document emailed within 1 workday
Related Documents
Urbannek, V.; Voth, E.; Moka, D.; Schicha, H. 2001: Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents NUKLEARMEDIZIN. Nuclear Medicine 40(4): 111-115Schicha, H.; Dietlein, M. 2002: Graves' disease nd toxic nodular goiter--radioiodine therapy NUKLEARMEDIZIN. Nuclear Medicine 41(2): 63-70
Ursu, H.I.; Dumitriu, L.; Grigorie, D.; Simescu, M.; Vaida, E.; Belgun, M.; Popovici, D. 1993: Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease) Romanian Journal of Endocrinology 31(3-4): 155-163
Calegaro, J.U.; De Freitas Gomes, E.; Bae, S.H.; Ulyssea, R.; Casulari, L.A. 2000: One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration Panminerva Medica 42(4): 241-245
Bałdys-Waligórska, A.; Stefańska, A.; Gołkowski, F.; Sokołowski, G.; Hubalewska-Dydejczyk, A. 2009: Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy Przeglad Lekarski 66(4): 166-169
Schiavo, M.; Bagnara, M.C.; Pomposelli, E.; Altrinetti, V.; Calamia, I.; Camerieri, L.; Giusti, M.; Pesce, G.; Reitano, C.; Bagnasco, M.; Caputo, M. 2013: Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(3): 301-307
Smyczńyska, J.; Cyniak-Magierska, A.; Stasiak, M.; Karbownik-Lewińska, Młgorzata.; Lewiński, A. 2014: Persistent remission of Graves` disease or evolution from Graves' disease to Hashimoto's thyroiditis in childhood - a report of 6 cases and clinical implications Neuro Endocrinology Letters 35(5): 335-341
Moser, E. 1997: Radioiodine therapy of Basedow's disease--is there a therapeutic standard? Zentralblatt für Chirurgie 122(4): 227-230
Stanbury, J.B. 1970: The choices of therapy in Graves' disease Medical Times 98(11): 105-120
Krohn, T.; Meyer, P.T.; Ocklenburg, C.; Knollmann, D.; Nowak, B.; Schaefer, W.M. 2008: Stunning in radioiodine therapy of benign thyroid disease. Quantification and therapeutic relevance NUKLEARMEDIZIN. Nuclear Medicine 47(6): 248-254
Fazakas, S.; Kiss, B.; Erdei, I.; Petrányi, G. 1975: Hypothyreosis after I-131 therapy of Graves-Basedow disease Orvosi Hetilap 116(43): 2523-2526
Feldt-Rasmussen, U.F.; Glinoer, D.; Orgiazzi, J. 1995: Reevaluation of antithyroid drug therapy in Graves disease Ugeskrift for Laeger 157(1): 25-29
Winsa, B.; Rastad, J.; Larsson, E.; Mandahl, A.; Westermark, K.; Johansson, H.; Juhlin, C.; Karlsson, A.; Akerström, G. 1994: Total thyroidectomy in therapy-resistant Graves' disease Surgery 116(6): 1068-74; Discussion 1074-5
Escobar Jiménez, F.; Luna López, V.; Fernández Soto, M.L.; Quezada Charneco, M.; Glinoer, D. 1998: Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995 Medicina Clinica 111(6): 205-210
Kung, A.W.; Pun, K.K.; Lam, K.S.; Choi, P.; Wang, C.; Yeung, R.T. 1990: Long-term results following 131i treatment for Graves' disease in Hong Kong Chinese--discriminant factors predicting hypothyroidism Quarterly Journal of Medicine 76(281): 961-967
Wei, S.; Fang, J. 1992: Cost-effectiveness analysis of short-term course and regular course of antithyroid drug therapy for Graves' disease Hua Xi Yi Ke da Xue Xue Bao 23(2): 217-220
Getsuwan, S.; Wiromrat, P.; Panamonta, O.; Panamonta, M.; Paireepinas, S. 2016: Effectiveness and Safety of Radioactive Iodine Therapy in Childhood Graves' Disease in Khon Kaen, Thailand Journal of the Medical Association of Thailand 99(Suppl 5): S112-S119
Turton, D.B.; Silverman, E.D.; Shakir, K.M. 1998: Time interval between the last dose of propylthiouracil and I-131 therapy influences cure rates in hyperthyroidism caused by Graves' disease Clinical Nuclear Medicine 23(12): 810-814
Poomthavorn, P.; Mahachoklertwattana, P.; Tapaneya-Olarn, W.; Chuansumrit, A.; Chunharas, A. 2002: Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease Journal of the Medical Association of Thailand 85 Suppl. 4: S1295-S1301
Müller-Fassbender, H.; Hess, H. 1975: Late lysis therapy of chronic arterial occlusion. a new way to improve results Münchener Medizinische Wochenschrift 117(37): 1461-1462